EHA Library - The official digital education library of European Hematology Association (EHA)

THE INCIDENCE OF ACUTE LEUKEMIA IN SOME REGIONS OF THE RUSSIAN FEDERATION.
Author(s): ,
Akhmerzaeva Zalina
Affiliations:
National Research Center for Hematology,Moscow,Russian Federation
,
Kulikov SM
Affiliations:
National Research Center for Hematology,Moscow,Russian Federation
,
Rusinov MА
Affiliations:
National Research Center for Hematology,Moscow,Russian Federation
,
Zotina EN
Affiliations:
Kirov clinic hospital,Kirov,Russian Federation
,
Gavrilova LV
Affiliations:
Mordovia republic hospital,Saransk,Russian Federation
,
Pristupa AS
Affiliations:
Ryazan regional clinical hospital,Ryazan,Russian Federation
,
Vopilina NA
Affiliations:
Tambov regional clinical hospital,Tambov,Russian Federation
,
Borisenkova EA
Affiliations:
Kaluga regional clinical hospital,Kaluga,Russian Federation
Parovichnikova E N
Affiliations:
National Research Center for Hematology,Moscow,Russian Federation
(Abstract release date: 05/19/16) EHA Library. Akhmerzaeva Z. 06/09/16; 134518; PB1618
Ms. Zalina Akhmerzaeva
Ms. Zalina Akhmerzaeva
Contributions
Abstract
Abstract: PB1618

Type: Publication Only

Background
The incidence of acute leukemia (AL) in US and European countries is about 5 per 100000 according data from cancer registries. Russian Federal Сancer Register (RFCR) reported AL incidence rate across the country as about 3 per 100000. 

Aims
To evaluate the age-gender specific incidence, profile and other epidemiologic characteristics AL in Russia regions. 

Methods
Russian Hematology Society in 2013 initiated the AL population based registry study in which participated 5 regions of Russia Federation. The primary goal was to pre-registry patients for clinical studies, and secondary - to evaluate the epidemiology of AL. 5 regions  were included into analysis of epidemiology statistics. The criteria were the fullness and reliability of AL cases registration. Also, only regions with one big hematological center accumulating all AL cases were chosen. All new cases were recorded on-line into special Web based data capture system. 

Results
The registry was started at 1st April of 2013 and is ongoing. 216 new ALL cases from Kirov, Ryazan, Kaluga, Tambov regions and Mordovia republic (4,7 M of population) were included into analysis. The distribution by AL subtypes was following:  AML - 131 (60,6%), ALL -  40 (18,5%), APL - 8(3,7%), other - 37 (17,1%). Median age was for AML - 59 (17-85), ALL -  38 (16-80), APL  55 (38-79) years. Gender female/male proportions 121\95. The incidence rate estimates by region are listed in table1. Table.1 Incidence of adult AL in 5 Russian regions.
regionAdult population (106)Registered casesDurationIncidence
AllMFAllMF(y)AllMF
Kirov1.150.520.634722252.141.901.981.84
Mordovia0.720.330.405229232.063.494.312.81
Ryazan1.010.450.564517281.902.341.982.63
Kaluga0.880.390.483315182.031.841.861.83
Tambov0.950.430.523912271.982.061.412.60
 The frequencies of AL cases  in age strata are distributed as following:  5 (2,3%) - in 15-19 age group; 39 (18%) - in 20-39 age group; 78 (36,1%) - in 40-59 age group; 89 (41,2%) - in 60-79 age group; 5 (2,3%) - in 80-99 age group.

Conclusion
AL patients registered in the Russian Federation are younger then AL patients of European registries (AML -58years vs 71years; ALL - 38 years vs 54years, respectively). The significant percentage of unidentified variants AL (17.1 %)  is a significant problem. We should emphasize that the recorded incidence of AL in our study is quite low. It's close of morbidity estimations of RFCR, but notably lower than European and American registers. This discrepancy can be explained by significantly reduced registration activity and primary diagnostics of AL in the older age groups.

Session topic: E-poster

Keyword(s): Acute leukemia
Abstract: PB1618

Type: Publication Only

Background
The incidence of acute leukemia (AL) in US and European countries is about 5 per 100000 according data from cancer registries. Russian Federal Сancer Register (RFCR) reported AL incidence rate across the country as about 3 per 100000. 

Aims
To evaluate the age-gender specific incidence, profile and other epidemiologic characteristics AL in Russia regions. 

Methods
Russian Hematology Society in 2013 initiated the AL population based registry study in which participated 5 regions of Russia Federation. The primary goal was to pre-registry patients for clinical studies, and secondary - to evaluate the epidemiology of AL. 5 regions  were included into analysis of epidemiology statistics. The criteria were the fullness and reliability of AL cases registration. Also, only regions with one big hematological center accumulating all AL cases were chosen. All new cases were recorded on-line into special Web based data capture system. 

Results
The registry was started at 1st April of 2013 and is ongoing. 216 new ALL cases from Kirov, Ryazan, Kaluga, Tambov regions and Mordovia republic (4,7 M of population) were included into analysis. The distribution by AL subtypes was following:  AML - 131 (60,6%), ALL -  40 (18,5%), APL - 8(3,7%), other - 37 (17,1%). Median age was for AML - 59 (17-85), ALL -  38 (16-80), APL  55 (38-79) years. Gender female/male proportions 121\95. The incidence rate estimates by region are listed in table1. Table.1 Incidence of adult AL in 5 Russian regions.
regionAdult population (106)Registered casesDurationIncidence
AllMFAllMF(y)AllMF
Kirov1.150.520.634722252.141.901.981.84
Mordovia0.720.330.405229232.063.494.312.81
Ryazan1.010.450.564517281.902.341.982.63
Kaluga0.880.390.483315182.031.841.861.83
Tambov0.950.430.523912271.982.061.412.60
 The frequencies of AL cases  in age strata are distributed as following:  5 (2,3%) - in 15-19 age group; 39 (18%) - in 20-39 age group; 78 (36,1%) - in 40-59 age group; 89 (41,2%) - in 60-79 age group; 5 (2,3%) - in 80-99 age group.

Conclusion
AL patients registered in the Russian Federation are younger then AL patients of European registries (AML -58years vs 71years; ALL - 38 years vs 54years, respectively). The significant percentage of unidentified variants AL (17.1 %)  is a significant problem. We should emphasize that the recorded incidence of AL in our study is quite low. It's close of morbidity estimations of RFCR, but notably lower than European and American registers. This discrepancy can be explained by significantly reduced registration activity and primary diagnostics of AL in the older age groups.

Session topic: E-poster

Keyword(s): Acute leukemia

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies